Skip to content
★ Sign in to follow
CI

Cytogenix Inc Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Skolnick Malcolm, was filed 14 May 2008.

Cytogenix Inc: what insiders have been doing

Cytogenix Inc is a listed company. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Cytogenix Inc in twelve months, the latest record being from 14 May 2008.

Over the whole record (from 2007), the tally stands at 6 purchases and no sales.

Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Insider Decl.
6
Thresholds
n/a
Buy Volume
€27,510
6 ops. · all time
Sell Volume
n/a
n/a

Financial data

· cache

Last declaration on 14 May 2008
Declarations6 total
  • ▲
    President/CEOExecutives
    10,000 USD0SEC
    166,667 shares@ US$0.06CytoGenix, Inc. Common StockSEC:0001121781-08-000226:0
    Canonical exit: 13 Jul 2008 (T+90)
  • ▲
    President/CEOExecutives
    3,750 USD0SEC
    15,000 shares@ US$0.25CytoGenix, Inc. Common StockSEC:0001121781-07-000378:0
    Canonical exit: 25 Feb 2008 (T+90)
  • ▲
    President/CEOExecutives
    7,500 USD0SEC
    30,000 shares@ US$0.25CytoGenix, Inc. Common StockSEC:0001121781-07-000370:0
    Canonical exit: 13 Feb 2008 (T+90)
  • ▲
    President/CEOExecutives
    5,000 USD0SEC
    20,000 shares@ US$0.25CytoGenix, Inc. Common StockSEC:0001121781-07-000371:0
    Canonical exit: 19 Feb 2008 (T+90)
  • ▲
    President/CEOExecutives
    4,200 USD0SEC
    15,000 shares@ US$0.28Common StockSEC:0001121781-07-000311:0
    Canonical exit: 3 Jan 2008 (T+90)
  • ▲
    President/CEOExecutives
    10,150 USD0SEC
    35,000 shares@ US$0.29Common StockSEC:0001121781-07-000311:1
    Canonical exit: 3 Jan 2008 (T+90)

6 of 6 declarations

About Cytogenix Inc

Cytogenix Inc is a company listed on the XNAS market, specializing in the development of biopharmaceutical technologies. It focuses on the research and production of innovative biological products.